In Brief Pulecio et al. show that a cocktail of six transcription factors converts human and murine fibroblasts to megakaryocyte progenitors with in vitro and in vivo functionality. MK progenitors can also be generated from disease-corrected fibroblasts, demonstrating that MK progenitors with clinical potential can be generated in vitro from somatic cells.
INTRODUCTION
Transplantation of in-vitro-generated autologous megakaryocytes (MKs) has been proposed as a suitable alternative to conventional transfusions of allogeneic platelets to limit both alloimmunization and infection risks (Cho, 2015) . MKs are responsible for the production of platelets. MKs are derived from hematopoietic stem cells (HSCs) in a process known as megakaryopoiesis, which consists of a series of events that can be divided in two steps: differentiation and maturation. Differentiation occurs after HSCs proliferate and commit to the myeloid lineage, giving rise to common myeloid progenitors that differentiate into bipotent megakaryocyte-erythrocyte progenitors (MEPs) (Pang et al., 2005) . In turn, MEPs give rise to MK and erythroid progenitors. A subsequent differentiation step toward the MK lineage is mainly driven by thrombopoietin (TPO) and can be traced by the loss of the pan-hematopoietic marker CD45 and the appearance of the fingerprint of the MK lineage, the integrin aIIb or CD41. On the other hand, MK maturation involves cellular polyploidyzation and the development of a complex system of membranes that are the scaffolds for the formation of the proplatelets and subsequent platelets (Debili et al., 1996; Patel et al., 2005) .
Several studies have identified a set of transcription factors (TFs), including TAL-1, RUNX1, ERG, LMO2, FLI1, and GATA-2, which are essential throughout hematopoiesis (Doré and Crispino, 2011; Loose et al., 2007) . In the context of MEP differentiation, a complex interplay among C-MYC, FOG1, GATA1, GATA2, RUNX1, and SCL determines the commitment to a specific lineage (Tijssen et al., 2011) . In particular, it has been shown that the upregulation of GATA2, RUNX1, and C-MYC represses the erythroid differentiation program and promotes the differentiation toward MK progenitors (Guo et al., 2009; Kuvardina et al., 2015) . Likewise, terminal megakaryocytic differentiation is controlled by other TFs, including p45NFE2, MAF-G, and MAF-K, which form a protein complex that regulates the expression of platelet-characteristic proteins such as B-tubulin class VI and thromboxane synthase (Lecine et al., 2000; Shivdasani et al., 1995; Wang et al., 1986) .
So far, platelets have been obtained from HSCs (Sim et al., 2016) , although the availability of these cells in patients with bone marrow failure (BMF) syndromes is very limited (Ceccaldi et al., 2012) . Similar approaches have been pursued from induced pluripotent stem cells (iPSCs) (Feng et al., 2014; Nakamura et al., 2014) , although the low efficiencies of the reprogramming and differentiation protocols, in addition to the time required for each step, are current limitations for their clinical implementation in chronical platelet-deficit conditions (Cho, 2015) . A revolutionary alternative to the classical procedures based on platelet transfusion therapies consists of the transplantation of MK progenitors able to engraft and release functional platelets into the circulation (Fuentes et al., 2010; Wang et al., 2015) . These results encourage the search for suitable protocols to generate patient-specific MK progenitors in vitro with clinical potential as an alternative to classical procedures of platelets transfusion from allogeneic donors.
As an alternative to somatic cell reprogramming and subsequent iPSC differentiation, the generation of blood cells by direct conversion strategies has proved to be a faster and more efficient way to convert somatic cells into terminally differentiated cells bypassing the pluripotent state (Ebina and Rossi, 2015; Xu et al., 2015) . Recently, our groups have shown that the overexpression of a set of TFs, including Gata1, Lmo2 , and c-Myc, directly converts human and murine fibroblasts into erythroid progenitors with the ability to express both fetal and adult globins (Capellera-Garcia et al., 2016) . Considering these results in the context of TFs known to be important for MEP differentiation, we hypothesized that the transdifferentiation process could be skewed to favor the megakaryocytic lineage under specific conditions that recapitulate the differentiation events observed in vivo.
In this study, we demonstrate that overexpression of Gata2 and Runx1 in combination with the TF core (Gata1, Tal-1, Lmo2, and c-Myc) directly converts human and murine fibroblasts into CD41 + cells resembling bona fide MK progenitors in vitro. When transplanted into immunocompromised mice, MK-like progenitors were able to engraft and differentiate into functional MKs capable of producing CD41 + /CD42 + platelets. The relevance of this approach has been also demonstrated in a clinically relevant BMF disease model by converting genecorrected fibroblasts from Fanconi anemia (FA) patients to MK-like cells.
RESULTS

Gata2 and Runx1 Bias the Direct Conversion of Human Fibroblasts to MK-like Progenitors
A recent study showed that human and murine fibroblasts can be directly converted to erythroid progenitors when a set of murine TFs composed of Gata1, Lmo2, is overexpressed in culture conditions that include the presence of erythropoietin (EPO) (Capellera-Garcia et al., 2016) . Due to the common origin of erythroid and MK progenitors, we wondered if this system could be a starting point for the generation of MK cells from human somatic cells. Thus, we tested if the addition of TPO to the culture medium could bias the cellular conversion toward the MK lineage. To test this hypothesis, fibroblasts from two independent healthy donors were retrovirally transduced with the four murine TFs (GTLM) or with ''all minus one'' combinations in the presence of both EPO and TPO (Figures 1A and S1A) . Thereafter, we monitored the presence of CD235 + (early erythroid marker) and CD41 + (early MK marker) cells during 12 days. We observed that the overexpression of GTLM caused the emergence of large rounded cells expressing CD41 or CD235, starting at day 4 and reaching at day 12 percentages of 10.9% ± 1.4% and 7.4% ± 3.3%, respectively ( Figure 1B) . Excluding a single factor from the GTLM cocktail was enough to completely block the generation of CD41 + cells ( Figure S1A ).
These results encouraged us to search for additional TFs that would boost the differentiation toward the MK lineage. Several groups have demonstrated that GATA2 and RUNX1 play an essential role in the progression of MEP differentiation toward the MK lineage and subsequent MK maturation (Kuvardina et al., 2015; Tijssen et al., 2011) . Hence, we decided to test if the addition of Gata2 and/or Runx1 to the TF cocktail would increase the efficiency of the conversion process.
Following the previous strategy to detect CD41 + and CD235 + cells, we observed that addition of each single factor Runx1 or Gata2 to the GTLM cocktail did not cause significant effects on the percentages of conversion (p > 0.05, n = 3). However, addition of both Gata2 and Runx1 to the GTLM cocktail resulted in a significant increase in the percentage of CD41 + cells after 12 days (21.14% ± 3.6% compared to 10.91% ± 1.4% for GTLM alone, n = 3, p < 0.05) ( Figure 1B ). Interestingly, CD41 + cells did not co-express CD34 or CD45 markers, suggesting a direct conversion process in which the generation of intermediate hematopoietic progenitors is omitted ( Figure S1C ).
The presence of CD41 + cells prompted us to search for culture conditions that would enable the generation of MK progenitors from human fibroblasts. We hypothesized that the addition of cytokines, molecules, and factors reported to support the culture of MKs derived from CD34 + cells (Emmrich et al., 2012) would increase the efficiency of the transdifferentiation. To test this, we followed two schemes of transdifferentiation. The first strategy was based on a two-phase differentiation system where an initial basal medium with TPO, interleukin-3 (IL-3), and stem cell factor (SCF) was replaced at day 4 for a more definitive medium (MK medium) including IL-6, IL-9, Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor, low-density lipoprotein (LDL), and nicotinamide. The second strategy consisted of culturing the cells with the MK medium from the beginning of the conversion process ( Figure 1C) .
We monitored the percentage of CD41 + and CD41 + /CD42 + at days 4, 8, and 12 after transduction. We observed that the sole use of the MK medium from the beginning of the culture caused a significant increase in the efficiency of conversion at both day 8 and day 12 (p < 0.001 and p < 0.05, n = 3), producing a higher number of CD41 + cells ($70%) after 12 days than the two-phase strategy ($40%). More importantly, we detected the presence of CD41 + /CD42 + cells (a hallmark of mature MKs) after 8 days in culture, although with low efficiency ($1.5%) ( Figure 1D ). Remarkably, we observed a low variability in the efficiency of the transdifferentiation to CD41 + cells between experiments regardless of the fibroblast source (Table S1 ) and a clear reduction in the percentage of CD41 + cells obtained after 12 days with the GTLM cocktail ( Figure S1D ). Likewise, the culture of nontransfected fibroblasts with the MK medium was not enough to foster the conversion toward CD41 + cells ( Figure S1B (legend continued on next page) ( Figure 1E ). Detailed analysis of these data show significant upregulation of genes specifically expressed in mature MKs, such as B-tubulin class VI, CD42a, FOG1, and p45NF-E2, when the fibroblasts were transduced with the GTLM + Runx1/ Gata2 TF cocktail compared to the ones transduced with the GTLM cocktail ( Figure S1E ). Importantly, overexpression of the murine TFs had a strong impact on the expression levels of their endogenous human counterparts. S1F ). We also tested the presence of multipotent progenitors of non-megakaryocytic lineages in bulk cultures of fibroblasts transdifferentiated with GTML or with the six-TF cocktail, using standard MethoCult assays, and could not detect hematopoietic colonies after 14 days in either condition (n = 4; data not shown).
In Vitro Differentiation of MK-like Progenitors
In addition, we analyzed the nuclear content of the converted cells and detected the presence of CD41 + cells with ploidies reaching %8N ( Figures 2B and S2B ). Remarkably, all the characteristics above mentioned were absent in cultures of human fibroblasts transduced with the GTLM cocktail without Runx1/ Gata2 ( Figure S1G ). Next, we wondered if the MK-like induced cells obtained from human fibroblasts could produce platelets in vitro. Thus, we recovered the platelet-like particle (PLP)-enriched fraction from the supernatant of the cell cultures and checked for the presence of CD41 + events. We detected the appearance of CD41
À PLPs in the supernatants of cells converted with the six TFs and cultured with MK medium ( Figure 2C ). The presence of platelets was corroborated by transmission electron microscopy (TEM) and compared to platelets derived in vitro from cord blood progenitors ( Figure 2D ). The low numbers of PLPs produced in vitro advised against the use of standard aggregation tests. However, we tested the functionality of the PLPs by performing previously standardized tests, such as spreading on activated glass and P-selectin expression (Feng et al., 2014) , based on the presence of vital (calcein + ) platelets in the cell cultures ( Figure 2E ). We observed that PLPs derived in vitro were able to spread on activated glass and form ''filopodia-like'' membrane protrusions resembling the early stages of aggregation as observed in the control platelets (Figures 2F and S2D ; Movies S1 and S2). In addition, we detected the presence of vital platelets expressing CD62p before agonist challenge. However, the percentage of CD62p + platelets did not change after incubation with a mix of thrombin and ADP (see Experimental Procedures and Supplemental Experimental Procedures). In contrast, a low percentage of platelets derived in vitro from cord blood progenitors increased the expression of CD62p upon agonist challenge ( Figure S2C ).
Direct Conversion of Mouse Fibroblasts to MK-like Progenitors
Once we observed that human fibroblasts could be converted into functional MK-like progenitors, we decided to test this protocol with mouse fibroblasts, since the murine model is more amenable to in vitro and in vivo functional analyses (Sykes and Scadden, 2013) .
We retrovirally transduced the set of four TFs (GTLM) and six TFs (GTLM plus Runx1/Gata2) into mouse embryonic fibroblasts (MEFs) cultured with the MK medium. We monitored the presence of hematopoietic (CD45), erythroid (Ter-119), and/or megakaryocytic (CD41) cells for 12 days. The appearance of large rounded cells at day 4 coincided with the emergence of CD41 + /CD45 À cells ($8%) and lasted until day 12 in both conditions. In contrast with the results obtained with human fibroblasts, no erythroid cells were found at any time point during the conversion process ( Figures 3A  and S3A ). Due to the relatively low percentages of differentiation and looking for a pure population to characterize the phenotype of the MK-like progenitors in culture, we FACS sorted the CD41 + cells after 12 days of differentiation generated by both strategies (GTLM and GTLM + Runx1/Gata2). Remarkably, only the CD41 + population produced by the overexpression of the six TFs gave rise to an expandable population that was kept in culture for at least 2 weeks and reached a $30-fold increase in the number of CD41 + cells, while high-purity cultures ($70%) were maintained ( Figures 3A and 3B ). Next, we proceeded to study the gene expression profile of the CD41 + purified population and compared it to MK progenitors from murine bone marrow samples (CD34 + /CD41 + ) and to CD41 + populations obtained during the transdifferentiation. We detected a gradual increase in the expression of MK-specific genes such as Nf-e2, B-tubulin VI, CD41, and CD42b, Mpl, and Fli-1 over the conversion process until they reached levels of expression similar to the positive controls. As observed in the human model, the use of the GTLM cocktail produced significantly fewer CD41 + cells with a gene Figure 3D ). Then, we proceeded to functionally test the progenitor capacity of the CD41 + transdifferentiated cells. By measuring the cellular ploidies, we observed that the purified CD41 + population contained polyploid cells reaching %8N ( Figure 3E ). Moreover, the functional characterization of MK-like progenitors in standard MegaCult assays revealed the presence of CFU-MKs after 12 days in culture, resembling the results obtained with MK endogenous progenitors from bone marrow ( Figure 3D ). Figure 3F ). Then, using TEM assays, we corroborated the presence of platelets in the cell cultures, which resembled the morphology of bona fide platelets from peripheral murine blood ( Figure 3G ). Next, as observed with human PLPs, we detected the presence of vital platelets ( Figure 3H ) able to spread on activated glass and to form membrane filopodia-like protrusions ( Figure 3I ; Movie S3). Last, we looked for the expression of CD62p by platelets derived in vitro after challenging them with agonists. As observed in the human model, we detected a similar population of CD62p + PLPs in the murine cell cultures that did not increase upon agonist challenge ( Figure S3D ). capacity to engraft and differentiate comparable to that of positive control cells ( Figures 4D, 4F , and S4). Altogether, this set of results shows that MK-like progenitors generated in vitro by the overexpression of GTLM + Gata2/Runx1 are able to engraft and mature in vivo.
MK-like Progenitors
Direct Conversion of MK-like Progenitors from Fibroblasts of Fanconi Anemia Patients
To provide proof of concept for the clinical potential of our transdifferentiation protocol, we tested it in a context where the generation of functional MKs would be clinically relevant. FA is a disease in which thrombocytopenia frequently constitutes one of the earliest events of BMF (Pawlikowska et al., 2014; Río et al., 2002) and the number of HSCs is markedly reduced. In order to test our protocol, we used both uncorrected (GFP-FA) and gene-corrected fibroblasts Both GFP-FA and FANCA-FA fibroblasts were able to produce CD41 + cells in a way similar to that observed with healthy fibroblasts. However the percentage of MK-like cells was significantly higher in gene-corrected FA fibroblasts compared to GFP-FA fibroblasts ( Figure 5A ). 5D , and S5C). Finally, we analyzed the PLP fraction in MK-like cultures derived from GFP-FA and FANCA-FA fibroblasts in order to detect the presence of platelets. Remarkably, we were able to detect a CD41 + PLP population only when FA fibroblasts were gene-corrected, although with lower efficiencies compared to healthy fibroblasts ( Figure 5E ). However, when we performed TEM, calcein assays, adhesion to activated glass, and activation upon agonist challenge experiments, we found that the platelets derived from FANCA-FA fibroblasts were roughly functionally equivalent to platelets derived from healthy fibroblasts (Figures 5F, 5H, and S5D; Movie S4).
DISCUSSION
Previous reports on direct reprogramming to hematopoietic lineages described the generation of rather primitive blood progenitors with a marked myeloid differentiation capacity (Batta et al., 2014; Ebina and Rossi, 2015; Pulecio et al., 2014; Szabo et al., 2010) . In contrast, in this work we described a transdifferentiation approach designed to produce blood lineagerestricted progenitors. Here, we show that human and mouse fibroblasts can be transdifferentiated into MK-like progenitors by overexpressing six TFs. In-vitro-generated MK-like progenitors showed hallmarks of MK identity, including the ability to form MK colonies, generate proplatelet-like structures, and produce vital platelets in vivo, and, when challenged in vivo, to engraft and give rise to mature MKs and platelets.
Direct transdifferentiation of fibroblasts to mature MK-like cells was reported through overexpression of only three TFs (p45NF-E2, Maf-G, and Maf-K) (Ono et al., 2012) . None of these factors alone or in combination had any significant effect on the efficiency of transdifferentiation to MK-like progenitors achieved with our system (data not shown). This suggests that the molecular mechanisms underlying cell-fate conversion in our approach compared to the previous one are independent. In this respect, we reasoned that direct conversion toward lineage-restricted progenitors, rather than terminally differentiated cells, would be advantageous for the megakaryocytic lineage, since mature MK have limited proliferation ability and engraftment potential. The benefits of generating progenitor-like cells by direct reprogramming have already been noted in other contexts, including neural (Han et al., 2012; Lujan et al., 2012; Ring et al., 2012) , hepatic (Yu et al., 2013) , and cardiac (Lalit et al., 2016) progenitors.
In order to respond to the demand of platelets, two strategies have been proposed. The first is the generation of functional clinical-grade platelets that could be banked and available for their immediate supply. This strategy has been previously described and is based on the differentiation of CD34 + progenitors and/or iPSCs (Feng et al., 2014; Nakamura et al., 2014) . On the other hand, clinical conditions causing a chronic deficit of platelets, such as the thrombocytopenia observed in FA patients, would require a different solution. In this scenario, the generation of engraftable MK progenitors would be an ideal tool to develop. In the light of this, the process of direct conversion described here, which takes only 12 days and generates MK-like progenitors able to differentiate and produce platelets in vivo with a $30-fold expansion capacity, provides a practically feasible setup for clinical implementation. Nonetheless, when we tested the ability to engraft of the human MK progenitors in vivo, we did not detect the presence of human CD41 + cells after 2 weeks of transplantation (data not shown). A possible explanation for this could be that speciesspecific signals for maintaining a progenitor-like phenotype could not be fully recapitulated in the human system in vitro (Riddell et al., 2014) or provided by the mouse niche(s) upon transplantation. While further research will be necessary to characterize the species-specific requirements for maintaining a MK-like progenitor phenotype, our combined results demonstrate that the activation of the MK lineage program induced by overexpressing GTLM + Runx1/Gata2 is conserved in both human and mouse fibroblasts. While the main goal of this study was not to generate platelets in vitro with direct clinical applications, the functionality of the MK progenitors was corroborated when we detected vital platelets in the cell cultures of the transdifferentiated fibroblasts. However, the numbers and the functionality of the platelets observed suggests that future projects aiming to generate large-scale functional platelets in vitro would require specific culture systems to control for shear stress, temperature restrictions, and the use of metalloprotease inhibitors, among other conditions ( Figures S1I, S3E , and S5E) (Sim et al., 2016; Wang et al., 2015) .
Throughout hematopoiesis, TFs command the induction and maintenance of the expression of lineage-specific genes, as well as the suppression of competing gene expression programs (Orkin and Zon, 2008; Pimanda and Gö ttgens, 2010) . TAL-1, RUNX1, GATA2, GATA1, and LMO2 make part of a cluster of TFs that are crucial to define and maintain HSC as well as MEP, erythroid, and MK identity (Loose et al., 2007; Robb et al., 1996; Tijssen et al., 2011) . This occurs because identical sets of TFs may play opposing roles at different steps of lineage commitment depending on the specific cellular context in which they are expressed. In the context of forced cell-fate conversion, the role of these TFs may be modified and have a different effect on the cellular outcome (Graf and Enver, 2009) .
Exogenously overexpressed TFs can act as activators or repressors depending on the epigenomic landscape and the relative amounts of the endogenous TFs expressed in the somatic cell to be reprogrammed (Vierbuchen and Wernig, 2011) . In Figure 2D ).
(G) The presence of vital platelets in the culture produced by gene-corrected FA fibroblasts was analyzed by calcein assays. Representative dot plots are shown (see Figure 2E) . (H) The formation of membrane protrusions distinctive of the early stages of platelet aggregation was studied by adhesion of PLPs to activated glass. Images from time-lapse experiments performed over 20 min are shown. The morphology of the platelets is followed by bright-field images (bottom) and light reflection (top) ( Figure 2F ).
this direction, we previously established that overexpression of GATA-1, TAL-1, LMO2, and C-MYC is sufficient to induce the conversion of fibroblasts to erythroid progenitors (CapelleraGarcia et al., 2016) . Taking these observations into account, the results of our current study are consistent with previous reports that demonstrate that GATA2 and RUNX1 foster the generation of MK progenitors by occupying a set of shared promoter regions bound by GATA1 in erythroid progenitors. In the context of MK lineage specification, it has been demonstrated that GATA2 binds the active promoter regions shared with GATA1 and causes the repression of their targets through the interaction with additional TFs such as FOG1 (Huang et al., 2009; Tsai et al., 1994) . Moreover, RUNX1 has been shown to interact with SCL, triggering the activation of FLI1 and recruiting a gene-activating complex to MK-related genes while repressing the erythroid program by inhibiting the activity of KLF1 (Kuvardina et al., 2015) . In addition to the instrumental role of TFs, instructions conferred by the culture conditions are essential to drive cell lineage conversion in direct transdifferentiation approaches (Daniel et al., 2016) . The results of our study clearly show that this is the case for MK lineage conversion as well, since the sole addition of TPO to the culture medium led to the appearance of MK-like progenitors using a TF cocktail previously shown to activate the erythroid lineage (Capellera-Garcia et al., 2016) . Further addition of cytokines and molecules that support MK maturation in vitro from cord blood progenitors (Emmrich et al., 2012) significantly increased the efficiency of the conversion of human fibroblasts. In an effort to provide proof of principle for the clinical applicability of the direct conversion strategy developed here, we reprogrammed fibroblasts from FA patients. FA is a BMF characterized by a reduced content of HSCs, which causes defective thrombocytopenia (Río et al., 2002) , as well as impaired endomitosis during megakaryopoiesis (Pawlikowska et al., 2014) . Our results indicate that prior gene complementation of FA fibroblasts with a healthy copy of the FANCA gene, significantly improved their ability to transdifferentiate to MK-like cells when compared to uncorrected FA fibroblasts. This is consistent with previous studies showing that FANCA is required for effective megakaryopoiesis of mouse HSCs (Pawlikowska et al., 2014) . Although our results should be considered preliminary in the clinical context, they open the road to exploring further characterization and development of MK progenitors derived from gene-corrected fibroblasts from FA patients and from other diseases requiring platelet transfusion, especially in those cases in which the HSCs content is also affected.
The clinical translation of this approach would also require addressing several important shortcomings. Chief among them the issue of safety of the transdifferentiated cells should be thoroughly examined before any treatment of human patients is attempted. In this regard, the use of inducible systems or non-integrative delivery methods for achieving TF overexpression in fibroblasts should be developed, a goal that will undoubtedly benefit from the remarkable advances in the field of induced reprogramming to pluripotency (Brouwer et al., 2016; Schlaeger et al., 2015) . In particular, mRNA reprogramming has been shown as an appealing alternative that conforms to the limitations imposed for clinical-grade procedures, without affecting the efficiency of reprogramming (Ebina and Rossi, 2015) . In addition to the generation of autologous MK-like progenitors, the methods described here provide the foundation for future studies aimed at producing functional platelets in vitro using direct cell-fate conversion. Future studies on the direct reprogramming of fibroblasts to MK-like progenitors will be important for advancing the applicability of this approach.
EXPERIMENTAL PROCEDURES Derivation of Mouse Embryonic Fibroblasts
All experiments involving animal subjects were conducted following procedures approved by the Ethics Committees on Experimental Animals of the Barcelona Biomedical Research Park. At least two 14.5 embryos were collected from CD1 mice decapitated while the liver was pulled out. Decapitated embryos were minced, treated with trypsin/EDTA 0.05% in presence of penicillin/streptomycin and after pipetting were incubated at 37 C for 15min. Cellular content was filtered with a 40-mm cell strainer, washed with complete DMEM (DMEM plus 10%FBS [Gibco] plus Glutamax [Invitrogen] plus 50 U/mL penicillin and 50 mg/mL streptomycin [Invitrogen]), and centrifuged at 1,200 rpm for 5 min at room temperature. The pellet was resuspended in complete DMEM and plated in a 15-cm dish. Cells were split once and mycoplasma tested.
Human Fibroblasts
Experiments involving the procurement and use of samples from human subjects were conducted after approval by the Institutional Review Board at Center of Regenerative Medicine in Barcelona (CMRB) and/or Centro de Investigaciones Energé ticas, Medioambientales y Tecnoló gicas (CIEMAT). Two primary fibroblast lines were derived from human skin biopsy specimens obtained with informed consent from patients. For experiments with FA samples, skin fibroblasts were obtained from patient FA-707 after informed consent was signed. All three lines were negative for hematopoietic markers, including CD34. Fibroblasts were cultured in complete DMEM. All cell lines were maintained in an incubator (37 C, 5% CO 2 ), with media changes every second day.
Retroviral and Lentiviral Vector Production and Transduction
Coding regions for the candidate genes (Lmo2, Gata1, Gata2 , and Runx1 and EGFP) were amplified and cloned into pMXs retroviral vector backbone. For retrovirus production, 4 3 10 6 Phoenix-AMPHO cells were seeded in Opti-MEM (Gibco) and transfected with Fugene6 (Promega) DNA mix (3:1 ratio). Culture medium was switched to complete DMEM the day after; fresh virus productions were filtered through a 0.45-mm filter and were collected after 24 and 48 hr.
For the experiments with FA fibroblasts, vectors containing PGK-FANCA and PGK-EGFP were used to generate third-generation self-inactivating lentiviruses (LVs) pseudotyped with vesicular stomatitis virus-G protein (VSV-G) envelopes. Lentiviral particles were prepared by four-plasmid calcium phosphate-mediated transfection in 293T cells, essentially as previously described (Dull et al., 1998) , and vector stocks were titrated (Charrier et al., 2011) 1 3 10 5 fibroblasts were plated in p6 wells and transduced for 24 hr with an MOI 20 of PGK-EGFP-LV as a control vector or PGK-FANCA-LV (Gonzá lez- Murillo et al., 2010) . 24 hr later, cells were washed and used for trans-differentiation studies.
In Vivo Transplantation Experiments 100 mL PBS containing 100,000 CD41 + /CD42 À /GFP + in vitro transdifferentiated cells mixed with 100,000 unsorted cells isolated from the bone marrow of a healthy donor were injected into sub-lethally irradiated NSG mice (225 Gy) in the retro-orbital cavity. Blood samples were collected weekly. After 2-3 weeks, mice were sacrificed, and samples from peripheral blood, spleen, bone marrow, and lungs were collected. 
Statistical Evaluation
Statistical analyses were performed using unpaired Student's t and MannWhitney tests (one-tailed, 95% confidence intervals) using GraphPad 5.0 (Prism). All data are presented as mean ± SEM and represent a minimum of three independent experiments with at least three technical replicates. See Supplemental Experimental Procedures for a detailed description of the experimental design and reagents used in this study. 
